Evidence map›Paper›PMID 42390105›Full record

ArticleInfection and immunity2026

Phenotypic and genotypic analysis of

Amirhossein Davari, Junyan Liu, Jabez P Fortwendel, Arturo Luna-Tapia, David J Lowes, Jian Miao, Hubertine M E Willems, Christian A DeJarnette, Tracy L Peters, Nasim Ahmadi and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Amirhossein DavariPharmaceutical Sciences Graduate Program, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Junyan LiuDepartment of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Jabez P FortwendelPharmaceutical Sciences Graduate Program, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Arturo Luna-TapiaDepartment of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
David J LowesDepartment of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Jian MiaoPharmaceutical Sciences Graduate Program, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Hubertine M E WillemsDepartment of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA.ORCID 0009-0004-1910-6558
Christian A DeJarnetteDepartment of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Tracy L PetersDepartment of Pharmacy and Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Nasim AhmadiPharmaceutical Sciences Graduate Program, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Surabhi NaikResearch Bioinformatics Core, Rush University, Chicago, Illinois, USA.
Marc SwidergallDivision of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, California, USA.ORCID 0000-0002-5261-6267
P David RogersDepartment of Pharmacy and Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-4401-0679
Jack D SobelDepartment of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA.ORCID 0000-0002-5589-4609
Glen E Palmer *Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA.ORCID 0000-0003-4083-3130
Brian M Peters *Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA.ORCID 0000-0002-0445-2077

Funding

Candidalysin: a key mediator of Candida vaginitis immunopathologyR01AI134796 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI Brian M Peters · 2018 to 2026
$2.9M
Targeted and forward genetic approaches to decipher the pathogenesis of symptomatic vulvovaginal candidiasisR21AI141829 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI PETERS, BRIAN M · 2019 to 2020
$418k
A novel role for the inflammasome in the immunopathogenesis of Candida vaginitisK22AI110541 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI PETERS, BRIAN M · 2016 to 2017
$268k
NIAID NIH HHS K22 AI110541NIAID NIH HHS R01 AI134796NIAID NIH HHS R21 AI141829
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Candida albicansCandidiasis, VulvovaginalEndothelin-Converting EnzymesFungal ProteinsMetalloendopeptidasesVaginaAnimalsBiofilmsDisease Models, AnimalFemaleGenotypeHumansMicePhenotypeVirulenceVirulence FactorsECE1 protein, Candida albicansECE1 protein, humanEndothelin-Converting EnzymesFungal ProteinsMetalloendopeptidasesVirulence FactorsCandidacandidalysincandidiasismucosalvulvovaginalVVC

Identifiers

PMID42390105
PMCPMC13367051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.